Article Details

TRACON Pharmaceuticals (NASDAQ:TCON) Earns Sell Rating from Analysts at StockNews.com

Retrieved on: 2022-07-16 09:26:01

Tags for this article:

Click the tags to see associated articles and topics

TRACON Pharmaceuticals (NASDAQ:TCON) Earns Sell Rating from Analysts at StockNews.com. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 20,523 shares of the biopharmaceutical company's stock valued at $55,000 after buying an additional 6,451 shares ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up